Bicocca Open Archive

Logo unimib boa
BANDERA, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.569
AS - Asia 3.176
EU - Europa 2.072
SA - Sud America 500
AF - Africa 87
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.418
SG - Singapore 1.105
CN - Cina 691
VN - Vietnam 485
HK - Hong Kong 386
BR - Brasile 380
RU - Federazione Russa 375
DE - Germania 290
IT - Italia 276
IE - Irlanda 259
SE - Svezia 245
GB - Regno Unito 124
UA - Ucraina 109
FR - Francia 99
IN - India 97
CA - Canada 94
FI - Finlandia 70
BD - Bangladesh 55
DK - Danimarca 54
AR - Argentina 51
ID - Indonesia 44
TR - Turchia 44
IQ - Iraq 42
KR - Corea 38
ZA - Sudafrica 38
NL - Olanda 31
ES - Italia 28
JP - Giappone 28
MX - Messico 28
AT - Austria 24
PL - Polonia 24
PK - Pakistan 23
SA - Arabia Saudita 22
BE - Belgio 15
UZ - Uzbekistan 15
PH - Filippine 14
EC - Ecuador 13
VE - Venezuela 12
CL - Cile 11
IR - Iran 11
CO - Colombia 10
MA - Marocco 9
MY - Malesia 9
AU - Australia 8
HN - Honduras 8
KE - Kenya 8
NP - Nepal 8
UY - Uruguay 8
PY - Paraguay 7
AZ - Azerbaigian 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
EG - Egitto 6
ET - Etiopia 6
IL - Israele 6
JO - Giordania 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
EU - Europa 5
LB - Libano 5
TH - Thailandia 5
TN - Tunisia 5
BG - Bulgaria 4
BO - Bolivia 4
BZ - Belize 4
CR - Costa Rica 4
PE - Perù 4
PT - Portogallo 4
TW - Taiwan 4
AL - Albania 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
HR - Croazia 3
KH - Cambogia 3
LV - Lettonia 3
ML - Mali 3
MN - Mongolia 3
OM - Oman 3
RO - Romania 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
GR - Grecia 2
JM - Giamaica 2
MD - Moldavia 2
NG - Nigeria 2
PS - Palestinian Territory 2
QA - Qatar 2
SC - Seychelles 2
SI - Slovenia 2
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
Totale 10.407
Salva come PNG Salva come JPEG
Città #
Singapore 669
Ashburn 402
Hong Kong 379
Ann Arbor 375
San Jose 314
Fairfield 276
Chandler 271
Dublin 253
Houston 192
Woodbridge 186
Frankfurt am Main 181
Wilmington 174
New York 156
Ho Chi Minh City 143
Dallas 142
Los Angeles 130
Hanoi 116
Seattle 103
Jacksonville 100
Beijing 98
Dearborn 96
Cambridge 94
Milan 88
Santa Clara 75
Chicago 73
Princeton 71
The Dalles 67
Hefei 65
Shanghai 51
Buffalo 48
Nanjing 42
Lauterbourg 40
Helsinki 39
São Paulo 35
Seoul 33
Lawrence 32
Altamura 31
Moscow 31
Council Bluffs 28
Ottawa 28
Munich 27
Tokyo 26
Fremont 21
London 21
San Diego 21
Florence 20
Kent 20
Nanchang 20
Jakarta 19
Lachine 19
Baghdad 18
Denver 18
Dong Ket 18
Nuremberg 17
Rio de Janeiro 17
Toronto 17
Amsterdam 16
Hangzhou 16
Orem 16
Da Nang 15
Brooklyn 14
Brussels 14
Warsaw 14
Guangzhou 13
Salt Lake City 13
Vienna 13
Andover 12
Chennai 12
Edmonton 12
Shenyang 12
Tashkent 12
Brasília 11
Columbus 11
Jeddah 11
Johannesburg 11
Redondo Beach 11
Changsha 10
Durban 10
Haiphong 10
Hebei 10
Kunming 10
Boardman 9
Montreal 9
Quận Bình Thạnh 9
San Francisco 9
Atlanta 8
Biên Hòa 8
Boston 8
Buenos Aires 8
Bắc Ninh 8
Ha Long 8
Kiev 8
Norwalk 8
Paris 8
Poplar 8
Pune 8
Tianjin 8
Zhengzhou 8
Belo Horizonte 7
Can Tho 7
Totale 6.509
Salva come PNG Salva come JPEG
Nome #
Microbiota in ICU, not only a gut problem 342
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 340
Impact of orotracheal intubation and mechanical ventilation on the microbiota of the lung in the development of Ventilator- Associated Pneumonia 318
Effects of autologous stem cell transplantation in HIV: searching for the origins of viral replication in settings of profound CD4(+) T cell depletion 314
Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated with the Evolution of Cognitive Performance in HIV-Infected Patients 308
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 306
Brachial and central blood pressure in HIV-infected subjects 299
Strategies to limit immune-activation in HIV patients 297
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 292
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 289
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 281
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 281
ECMO: An alternative support for acute respiratory failure caused by tuberculosis? 267
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 265
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 260
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 255
Combination antifungal therapy for invasive mold infections among pediatric patients with hematological malignancies: Data from a real-life case-series 250
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the "cOPA" pilot randomized trial 250
Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study 240
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 238
Unmasking tuberculosis in the era of antiretroviral treatment 235
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 231
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 231
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 229
Use of CXCR4-antagonist for haematopoietic stem cell mobilization in HIV-infected patients with haematological malignancies 227
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 217
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 203
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 203
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 197
Characterization of immune failure by monocyte activation phenotypes in HIV-infected patients receiving antiretroviral therapy 196
Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals 195
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 193
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2 188
Early changes in adhesion molecules expression and endothelial function in patients initiating ART with Atazanavir or Lopinavir 188
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 181
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 175
Exogenous reinfection of tuberculosis in a low-burden area 175
Arterial structural and functional effects of two different antiretroviral therapy protocol on naïve HIV-infected subjects 173
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) 168
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 165
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 165
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 161
Plasma, Intracellular and Lymph Node Antiretroviral Concentrations and HIV DNA Change During Primary HIV Infection: Results from the INACTION P25 Study 156
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir 152
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 145
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 132
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 129
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 129
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 3
Totale 10.834
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 0 0 0 0 21 39
2021/2022474 15 21 46 60 20 48 21 36 23 55 29 100
2022/2023959 102 316 74 113 40 129 10 68 65 8 23 11
2023/2024754 19 14 46 32 92 217 144 37 52 23 6 72
2024/20251.813 88 181 125 90 147 78 131 38 206 318 155 256
2025/20264.315 675 331 438 467 537 243 592 189 349 438 56 0
Totale 10.834